AIP
RVMD icon

Ameritas Investment Partners’s Revolution Medicines RVMD Stock Holding History

Ameritas Investment Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,287
Closed -$611K – 3323
2025
Q1 		$611K Hold
17,287
– – 0.02% 741
2024
Q4 		$756K Buy
17,287
+2,131
+14% +$108K 0.02% 696
2024
Q3 		$687K Buy
15,156
+228
+2% +$9.93K 0.02% 735
2024
Q2 		$579K Buy
14,928
+1,017
+7% +$38K 0.02% 755
2024
Q1 		$448K Sell
13,911
-978
-7% -$29K 0.02% 863
2023
Q4 		$427K Buy
14,889
+4,813
+48% +$116K 0.02% 861
2023
Q3 		$279K Buy
10,076
+1,701
+20% +$50.5K 0.01% 988
2023
Q2 		$224K Buy
8,375
+1,587
+23% +$38.9K 0.01% 1067
2023
Q1 		$147K Buy
6,788
+950
+16% +$23.4K 0.01% 1281
2022
Q4 		$160K Hold
5,838
– – 0.01% 1290
2022
Q3 		$115K Buy
5,838
+1,181
+25% +$26K 0.01% 1399
2022
Q2 		$90K Hold
4,657
– – ﹤0.01% 1590
2022
Q1 		$119K Hold
4,657
– – ﹤0.01% 1520
2021
Q4 		$117K Hold
4,657
– – ﹤0.01% 1588
2021
Q3 		$128K Hold
4,657
– – ﹤0.01% 1535
2021
Q2 		$148K Buy
4,657
+1,183
+34% +$41.3K 0.01% 1473
2021
Q1 		$159K Buy
3,474
+187
+6% +$8.39K 0.01% 1356
2020
Q4 		$130K Hold
3,287
– – 0.01% 1422
2020
Q3 		$114K Buy
3,287
+2,067
+169% +$57.3K 0.01% 1353
2020
Q2 		$39K Hold
1,220
– – ﹤0.01% 1982
2020
Q1 		$27K Buy
+1,220
New +$33.8K ﹤0.01% 2010

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Ameritas Investment Partners's RVMD Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 17,287 shares — an estimated $611K sold.

Ameritas Investment Partners first reported a position in RVMD in Q1 2020 and held it in 21 quarters. The position peaked at $756K in Q4 2024. 307 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 17,287 Revolution Medicines shares in Q2 2025, an estimated $611K.
  • Ameritas Investment Partners first reported a position in Revolution Medicines in Q1 2020 and held it in 21 quarters.
  • Ameritas Investment Partners's Revolution Medicines position peaked at $756K in Q4 2024.
  • 307 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.